These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 30953889)

  • 1. Design and synthesis of parthenolide-SAHA hybrids for intervention of drug-resistant acute myeloid leukemia.
    Ge W; Liu Z; Sun Y; Wang T; Guo H; Chen X; Li S; Wang M; Chen Y; Ding Y; Zhang Q
    Bioorg Chem; 2019 Jun; 87():699-713. PubMed ID: 30953889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and anti-acute myeloid leukemia activity of C-14 modified parthenolide derivatives.
    Yang Z; Kuang B; Kang N; Ding Y; Ge W; Lian L; Gao Y; Wei Y; Chen Y; Zhang Q
    Eur J Med Chem; 2017 Feb; 127():296-304. PubMed ID: 28068601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and synthesis of parthenolide and 5-fluorouracil conjugates as potential anticancer agents against drug resistant hepatocellular carcinoma.
    Ding Y; Li S; Ge W; Liu Z; Zhang X; Wang M; Chen T; Chen Y; Zhang Q
    Eur J Med Chem; 2019 Dec; 183():111706. PubMed ID: 31553932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological evaluation of paclitaxel and vorinostat co-prodrugs for overcoming drug resistance in cancer therapy in vitro.
    Liu S; Zhang K; Zhu Q; Shen Q; Zhang Q; Yu J; Chen Y; Lu W
    Bioorg Med Chem; 2019 Apr; 27(7):1405-1413. PubMed ID: 30819618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of dithiocarbamate esters of parthenolide as potential anti-acute myelogenous leukaemia agents.
    Ding Y; Yang Z; Ge W; Kuang B; Xu J; Yang J; Chen Y; Zhang Q
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1376-1391. PubMed ID: 30208745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and structure-activity relationship studies of parthenolide derivatives as potential anti-triple negative breast cancer agents.
    Ge W; Hao X; Han F; Liu Z; Wang T; Wang M; Chen N; Ding Y; Chen Y; Zhang Q
    Eur J Med Chem; 2019 Mar; 166():445-469. PubMed ID: 30739826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3-Hydroxyisoindolin-1-one derivates: Synthesis by palladium-catalyzed CH activation as BRD4 inhibitors against human acute myeloid leukemia (AML) cells.
    Chen P; Yang Y; Yang L; Tian J; Zhang F; Zhou J; Zhang H
    Bioorg Chem; 2019 May; 86():119-125. PubMed ID: 30690335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The application of Heck reaction in the synthesis of guaianolide sesquiterpene lactones derivatives selectively inhibiting resistant acute leukemic cells.
    Ding YH; Fan HX; Long J; Zhang Q; Chen Y
    Bioorg Med Chem Lett; 2013 Nov; 23(22):6087-92. PubMed ID: 24095093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1,3,4-Oxadiazole-containing histone deacetylase inhibitors: anticancer activities in cancer cells.
    Valente S; Trisciuoglio D; De Luca T; Nebbioso A; Labella D; Lenoci A; Bigogno C; Dondio G; Miceli M; Brosch G; Del Bufalo D; Altucci L; Mai A
    J Med Chem; 2014 Jul; 57(14):6259-65. PubMed ID: 24972008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel benzotriazole N-acylarylhydrazone hybrids: Design, synthesis, anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis and FAK inhibition.
    Kassab AE; Hassan RA
    Bioorg Chem; 2018 Oct; 80():531-544. PubMed ID: 30014921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, and biological activity evaluation of a series of novel sulfonamide derivatives as BRD4 inhibitors against acute myeloid leukemia.
    Feng Z; Chen A; Shi J; Zhou D; Shi W; Qiu Q; Liu X; Huang W; Li J; Qian H; Zhang W
    Bioorg Chem; 2021 Jun; 111():104849. PubMed ID: 33798846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a melampomagnolide B analog as a potential lead molecule for treatment of acute myelogenous leukemia.
    Albayati ZAF; Janganati V; Chen Z; Ponder J; Breen PJ; Jordan CT; Crooks PA
    Bioorg Med Chem; 2017 Feb; 25(3):1235-1241. PubMed ID: 28049618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sesquiterpenoids from the roots of Inula helenium inhibit acute myelogenous leukemia progenitor cells.
    Ding Y; Pan W; Xu J; Wang T; Chen T; Liu Z; Xie C; Zhang Q
    Bioorg Chem; 2019 May; 86():363-367. PubMed ID: 30753990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Pyrazolo[3,4-d]pyrimidines as Potential Cytotoxic Agents: Design, Synthesis, Molecular Docking and CDK2 Inhibition.
    Maher M; Kassab AE; Zaher AF; Mahmoud Z
    Anticancer Agents Med Chem; 2019; 19(11):1368-1381. PubMed ID: 31038080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of novel glycogen synthase kinase-3α inhibitors: Structure-based virtual screening, preliminary SAR and biological evaluation for treatment of acute myeloid leukemia.
    Wang Y; Dou X; Jiang L; Jin H; Zhang L; Zhang L; Liu Z
    Eur J Med Chem; 2019 Jun; 171():221-234. PubMed ID: 30925338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and biological evaluation of novel SIRT3 inhibitors targeting both NAD
    Yang X; Ge G; Wang H; Liu T; Pan D; Zhao X; Chen X; Wang J; Zhang J; Zhang K; Yao D
    Eur J Med Chem; 2024 Oct; 276():116689. PubMed ID: 39053191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. O
    Li Q; Zou P; Sun J; Chen L
    Eur J Med Chem; 2018 Jan; 143():732-744. PubMed ID: 29220794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and in vitro evaluation of stilbene derivatives as novel LSD1 inhibitors for AML therapy.
    Duan Y; Qin W; Suo F; Zhai X; Guan Y; Wang X; Zheng Y; Liu H
    Bioorg Med Chem; 2018 Dec; 26(23-24):6000-6014. PubMed ID: 30448189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel benzimidazole-linked (thio)barbiturates as non-hydroxamate HDAC6 inhibitors targeting leukemia: Design, synthesis, and structure-activity relationship.
    Mansour RE; Abdulwahab HG; El-Sehrawi HM
    Arch Pharm (Weinheim); 2023 Jun; 356(6):e2200433. PubMed ID: 36942938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, Synthesis and Biological Evaluation of Novel Coumarin-Based Hydroxamate Derivatives as Histone Deacetylase (Hdac) Inhibitors with Antitumor Activities.
    Yang F; Zhao N; Song J; Zhu K; Jiang CS; Shan P; Zhang H
    Molecules; 2019 Jul; 24(14):. PubMed ID: 31311163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.